Russia says it is delivering its Avifavir medication against COVID-19 to 15 countries already.
Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF), which took part in the creation of the remedy, disclosed this to Russia-24 broadcaster in an interview.
“We can boast great achievements in this area, as the medication has been delivered to over 15 countries,” Mr Dmitriev said.
“This is really important, as there are in fact only two international antiviral drugs that are delivered to a certain number of countries: The United States’ Remdesivir and the Russian Avifavir.
“Ninety per cent of the produced Remdesivir have been purchased by the U.S.
“So, it is no surprise that 15 countries purchase our medication,” the RDIF CEO explained.
Earlier on Monday, Kromis — a joint venture of the RDIF and the ChemRar pharmaceutical company — announced it had reached agreement on Avifavir deliveries to South Africa and seven countries in Latin America.
Avifavir received a registration certificate of the Russian Ministry of Health in late May, becoming the world’s first favipiravir-based drug approved for treatment of COVID-19.
Support PREMIUM TIMES' journalism of integrity and credibility
Good journalism costs a lot of money. Yet only good journalism can ensure the possibility of a good society, an accountable democracy, and a transparent government.
For continued free access to the best investigative journalism in the country we ask you to consider making a modest support to this noble endeavour.
By contributing to PREMIUM TIMES, you are helping to sustain a journalism of relevance and ensuring it remains free and available to all.
TEXT AD: To advertise here . Call Willie +2347088095401...